Eagle Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.36 M | $8.79 M | 20.10% | 18.00% |
| AIGH CAPITAL MANAGEMENT LLC | 11/13/2024 | 1.21 M | $4.52 M | 0.00% | 9.25% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.00 M | $3.73 M | 0.00% | 7.64% |
| VANGUARD GROUP INC | 11/13/2024 | 579,507 | $2.16 M | 2.68% | 4.43% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 374,992 | $1.40 M | -46.18% | 2.86% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 268,169 | $1.00 M | 100.00% | 2.05% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 256,350 | $956,186 | 4.95% | 1.96% |
| MARSHALL WACE, LLP | 11/14/2024 | 223,353 | $833,107 | 14.26% | 1.71% |
| MORGAN STANLEY | 11/14/2024 | 192,213 | $716,955 | -36.02% | 1.47% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 185,058 | $690,266 | -17.69% | 1.41% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 183,592 | $684,798 | -0.94% | 1.40% |
| J. GOLDMAN & CO LP | 11/14/2024 | 150,611 | $561,779 | -21.19% | 1.15% |
| RBF CAPITAL, LLC | 11/14/2024 | 143,078 | $533,681 | 11.70% | 1.09% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 121,559 | $453,415 | 100.00% | 0.93% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 119,312 | $445,034 | -10.92% | 0.91% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 118,857 | $443,337 | 0.00% | 0.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 105,846 | $394,903 | -2.00% | 0.81% |
| INVESCO LTD. | 11/12/2024 | 82,775 | $308,751 | 0.43% | 0.63% |
| DGS CAPITAL MANAGEMENT, LLC | 12/10/2024 | 71,728 | $267,545 | 44.94% | 0.55% |
| UNION SQUARE PARK CAPITAL MANAGEMENT, LLC | 11/14/2024 | 56,963 | $212,472 | 100.00% | 0.44% |
| AJOVISTA, LLC | 11/12/2024 | 56,438 | $210.51 M | 402.48% | 0.43% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 54,625 | $203,751 | -68.06% | 0.42% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 51,006 | $190,253 | -84.33% | 0.39% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 43,723 | $163,087 | -17.43% | 0.33% |
| ROYAL BANK OF CANADA | 11/14/2024 | 36,925 | $138,000 | -1.80% | 0.28% |
| STATE STREET CORP | 11/14/2024 | 35,820 | $133,609 | 0.00% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 31,900 | $118,987 | 0.00% | 0.24% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 31,495 | $117,476 | -60.18% | 0.24% |
| PDT PARTNERS, LLC | 11/14/2024 | 30,011 | $111,941 | 0.00% | 0.23% |
| FMR LLC | 11/13/2024 | 28,348 | $105,738 | -2.79% | 0.22% |
| CITADEL ADVISORS LLC | 11/14/2024 | 26,013 | $97,028 | 100.00% | 0.20% |
| JANE STREET GROUP, LLC | 11/15/2024 | 25,837 | $96,372 | 100.00% | 0.20% |
| XTX TOPCO LTD | 11/14/2024 | 22,437 | $83,690 | 11.05% | 0.17% |
| CREATIVE PLANNING | 10/11/2024 | 15,686 | $58,509 | 100.00% | 0.12% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 11/12/2024 | 15,530 | $57,927 | 13.95% | 0.12% |
| BARCLAYS PLC | 11/19/2024 | 15,043 | $56,000 | -21.28% | 0.11% |
| ROYCE & ASSOCIATES LP | 11/06/2024 | 13,821 | $51,552 | 0.00% | 0.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 13,300 | $50,000 | 0.00% | 0.10% |
| BLAIR WILLIAM & CO/IL | 11/12/2024 | 12,952 | $48,311 | -1.13% | 0.10% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 12,890 | $48,000 | 100.00% | 0.10% |
| STANLEY-LAMAN GROUP, LTD. | 10/22/2024 | 12,000 | $44,760 | 0.00% | 0.09% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 10,734 | $40,038 | -11.94% | 0.08% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 8,355 | $31,000 | 100.00% | 0.06% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 7,773 | $28,993 | -33.06% | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 7,155 | $26,000 | -72.89% | 0.05% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 6,152 | $22,947 | -76.17% | 0.05% |
| WEALTHCOLLAB, LLC | 11/14/2024 | 5,617 | $20,952 | 28.39% | 0.04% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 3,561 | $13,283 | -63.66% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,702 | $10,078 | -15.46% | 0.02% |
| HIGHMARK WEALTH MANAGEMENT LLC | 10/17/2024 | 2,200 | $8,206 | 100.00% | 0.02% |
Eagle Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 145 institutional investors and hedge funds held shares of Eagle Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Nantahala Capital Management, LLC: 2.36 M
AIGH Capital Management LLC: 1.21 M
VANGUARD GROUP INC: 579,507
AQR CAPITAL MANAGEMENT LLC: 374,992
BlackRock Funding, Inc. /DE: 268,169
RENAISSANCE TECHNOLOGIES LLC: 256,350
65.36% of Eagle Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.90 M shares in the last 24 months. This purchase volume represents approximately $5.99 M in transactions.